The structural basis of hypertension: Vascular remodelling, rarefaction and angiogenesis/arteriogenesis

Journal of Hypertension

Volumn 23, Issue 8, 2005, Pages 1473-1475

  Bobik, Alex ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOSTATIN; BONE MORPHOGENETIC PROTEIN 4; ENDOSTATIN; ERYTHROPOIETIN; FIBRIN; FIBROBLAST GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; NITRIC OXIDE; NOTCH RECEPTOR; PLASMINOGEN; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; APOPTOSIS; AUTOREGULATION; BLOOD VESSEL; BLOOD VESSEL FUNCTION; CELL MATURATION; CELL PROLIFERATION; EDITORIAL; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE;

EID: 23344451741     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000174970.56965.4f     Document Type: Editorial

References (30)

1. Korner PI, Bobik A. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 1995; 25:610-619.
2. Hansen-Smith FM, Morris LW, Greene AS, Lombard JH. Rapid microvessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats. Circ Res 1996; 79:324-330.
3. Gobe G, Browning J, Howard T, Hogg N, Winterford C, Cross R. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J Struct Biol 1997; 118:63-72.
4. Antonios TFT, Singer DRJ, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension 1999; 33:998-1001.
5. Antonios TFT, Singer DJR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999; 34:655-658.
6. Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99:18873-1879.
7. Antionios TFT, Rattray FM, Singer DRJ, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 2003; 89:175-178.
8. Thurston G, Murphy TJ, Baluk P, Lindsey JR, McDonald DM. Angiogenesis in mice with chronic airway inflammation. Strain-dependent differences. Am J Pathol 1998; 153:1099-1112.
9. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6:389-395.
10. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, et al. Increased vascularisation in mice overexpressing angiopoietin-1. Science 1998;282:468-471.
11. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, et al. Angiogenic synergism, vascular stability and improved hind-limb ischaemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9:604-613.
12. Vogt CJ, Schmid-Schonbein GW. Microvascular endothelial cell death and rarefaction in the glucocorticoid-induced hypertensive rat. Microcirculation 2001; 8:129-139.
13. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1:1024-1028.
14. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999; 18:5356-5362.
15. Meeson AP, Argilla M, Ko K, Witte L, Lang RA. VEGF deprivation-induced apoptosis is a component of programmed capillary regression. Development 1999; 126:1407-1415.
16. Gale NW, Dominmguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 2004; 101:15949-15954.
17. Kiyono M, Shibuya M. Bone morphogenetic protein 4 mediates apoptosis of capillary endothelial cells during rat pupillary membrane regression. Mol Cell Biol 2003; 23:4627-4636.
18. Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodelling. Circ Res 2004;94:1203-1210.
19. Diez-Roux G, Argilla M, Makarenkova H, Ko K, Lang RA. Macrophages kill capillary cells in G1 phase of the cell cycle during programmed vascular regression. Development 1999; 126:2141-2147.
20. Struyker-Boudier HA, le Noble JL, Slaaf DW, Smits JF, Tangelder GJ. Microcirculatory changes in cremaster muscle during early spontaneous hypertension in the rat. J Hypertens Suppl 1988; 6:S185-S187.
21. Prewitt RL, Chen II, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 1982; 243:H243-H251.
22. Kubis N, Besnard S, Silvestre JS, Feletou M, Huang PL, Levy BI, Tedgui A. Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens 2002; 20:273-280.
23. Boegehold MA, Johnson MD, Overbeck HW. Pressure-independent arteriolar rarefaction in hypertension. Am J Physiol 1991; 261:H83-H87.
24. Hudlett P, Neuville A, Miternique A, Griffon C, Weltin D, Stephan D. Angiogenesis and arteriogenesis are increased in fibrin gel chambers implanted in pre-hypertensive SHR. J Hypertens 2005; 23:000-000.
25. Geer DJ, Swartz DD, Andreadis ST. In vivo model of wound healing based on transplanted tissue-engineered skin. Tissue Eng 2004; 10:1006-1017.
26. Vega F, Panizo A, Pardo-Mindan J, Diez J. Susceptibility to apoptosis measured by MYC, BCL-2 and BAX expression in arterioles and capillaries of adult spontaneously hypertensive rats. Am J Hypertens 1999; 12:815-820.
27. Tomassoni D, Mancinelli G, Mignini F, Sabbatini M, Amenta F. Quantitative image analysis of choroid and retinal vasculature in SHR: a model of cerebrovascular hypertensive changes? Clin Exp Hypertens 2002; 24:741-752.
28. Werber AH, Fitch-Burke MC, Harrington DG, Shah J. No rarefaction of cerebral arterioles in hypertensive rats. Can J Physiol Pharmacol 1990; 68:476-479.
29. Gabison E, Chang JH, Hernandez-Quintela E, Javier J, Lu PC, Ye H, et al. Anti-angiogenic role of angiostatin during corneal wound healing. Exp Eye Res 2004; 78:579-589.
30. Bake TL, Giordano FJ, Hickey RP, Huang Y, Nath AK, Peterson KL, et al. Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularisation. Proc Natl Acad Sci USA 2002; 99:7734-7739.